Evidence map›Paper›PMID 34349230›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

Correction to: Histological regression in melanoma: impact on sentinel lymph node status and survival.

Karina Aivazian, Tasnia Ahmed, Mary-Ann El Sharouni, Jonathan R Stretch, Robyn P M Saw, Andrew J Spillane, Kerwin F Shannon, Sydney Ch'ng, Omgo E Nieweg, John F Thompson and 2 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Karina AivazianMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Tasnia AhmedMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Mary-Ann El SharouniMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Jonathan R StretchMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Robyn P M SawMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-3354-806X
Andrew J SpillaneMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-8354-434X
Kerwin F ShannonMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-8538-3132
Sydney Ch'ngMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-4011-1253
Omgo E NiewegMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
John F ThompsonMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-2816-2496
Serigne N LoMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-5092-5544
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. richard.scolyer@health.nsw.gov.au.ORCID http://orcid.org/0000-0002-8991-0013

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34349230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.